Journal
ADVANCES IN ANATOMIC PATHOLOGY
Volume 20, Issue 1, Pages 39-44Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PAP.0b013e31827b665b
Keywords
prostate cancer; prognosis; tissue microarray; quota sampling
Categories
Funding
- Canary Foundation
- Pacific Northwest Prostate Cancer SPORE [P50CA097186]
- Department of Defense [W81XWH-11-1-0380]
Ask authors/readers for more resources
Tissue microarrays (TMAs) provide unique resources for rapid evaluation and validation of tissue biomarkers. The Canary Foundation Retrospective Prostate Tissue Microarray Resource used a rigorous statistical design, quota sampling, a variation of the case-cohort study, to select patients for inclusion in a multicenter, retrospective prostate cancer TMA cohort. The study is designed to definitively validate tissue biomarkers of prostate cancer recurrence after radical prostatectomy. Tissue samples from over 1000 participants treated for prostate cancer with radical prostatectomy between 1995 and 2004 were selected at 6 participating institutions in the United States and Canada. This design captured the heterogeneity of screening and clinical practices in the contemporary North American population. Standardized clinical data were collected in a centralized database. The project has been informative in several respects. The scale and complexity of assembling TMAs with over 200 cases at each of 6 sites involved unanticipated levels of effort and time. Our statistical design promises to provide a model for outcome-based studies where tissue localization methods are applied to high-density TMAs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available